AzTrials
AzTrials

Irreversible PulpitisNCT01561183

Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis

A study testing Indirect pulp capping (IPC), Direct pulp capping (DPC) and Miniature pulpotomy (MP) in people with Irreversible Pulpitis, run by Shahid Beheshti University of Medical Sciences at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To compare the effect of different VPT methods using Calcium Enriched Mixture (CEM) cement for management of human dental pulp with irreversible pulpitis. Read more about this study

Who is it for?
Ages 10 years and olderHealthy volunteers can take part
Conditions the study is for
Irreversible Pulpitis
What is being tested?
Indirect pulp capping (IPC), Direct pulp capping (DPC) and Miniature pulpotomy (MP)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
302 participants
Where
1 siteIran
Study dates
Mar 2012to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Carious permanent vital mature molar tooth with closed apex (with preoperative X-ray)
  • Positive response to EPT or cold test
  • patients willing to participate in study
  • Healthy subjects; absence of any systematic disorder
  • Age ≥ 10 years old
  • Both gender
  • Written informed consent

Who cannot join

  • Moderate or severe periodontitis; pockets >3mm
  • None restorable tooth
  • Internal or external root resorption
  • Root canal calcification
  • Non vital pulps
  • Analgesic taken within the last 8h
Show all 10Show fewer
  • Active systemic disease
  • Pregnancy or nursing
  • History of opioid addiction/abuse
  • Temporary residency

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • Imam Khomeini Dental Clinic

    Tehran

Other trials in Iran

About this study

Official title: Vital Pulp Therapy for Management of Irreversible Pulpitis in Human Permanent Teeth: A Randomized Clinical Trial.

To compare the effect of different VPT methods using Calcium Enriched Mixture (CEM) cement for management of human dental pulp with irreversible pulpitis.

Read the detailed description

The purpose of this randomized clinical trial is to demonstrate the effect of four methods of Vital Pulp Therapy (VPT) using a new endodontic bio-material [calcium enriched mixture (CEM) cement] in pain relief as well as clinical/radiographic success, for management of irreversible pulpitis of human permanent teeth.

Being tested
Indirect pulp capping (IPC), Direct pulp capping (DPC), Miniature pulpotomy (MP), Full pulpotomy (FP)
Keywords
Vital pulp therapy, Pulp cap, pulpotomy, calcium enriched mixture, CEM cement, Endodontic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect pulp capping (IPC)Procedure or surgery

    Also called Indirect pulp capping

    Procedure: IPC

    The IPC will be performed as follow:

    • Anesthesia
    • isolation the tooth
    • access to the lesion
    • incomplete removal of carious tissue from the cavity walls
    • indirect pulp capping with ≈2 mm layer calcium enriched mixture cement
    • permanent filling with sandwich technique
  • Direct pulp capping (DPC)Procedure or surgery

    Also called Direct pulp capping

    Procedure: DPC

    The DPC will be performed as follow:

    • Anesthesia
    • isolation the tooth
    • access to the lesion
    • complete removal of carious tissue from the cavity walls result in pulp exposure
    • preparation of clot-free pulpal mound
    • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
    • permanent filling with sandwich technique
  • Miniature pulpotomy (MP)Procedure or surgery

    Also called Miniature pulpotomy

    Procedure: MP

    The MP will be performed as follow:

    • Anesthesia
    • isolation the tooth
    • access to the lesion
    • complete removal of carious tissue from the cavity walls result in pulp exposure
    • intentionally removal of pulp horn (≈1 mm)
    • preparation of clot-free pulpal mound
    • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
    • permanent filling with sandwich technique
  • Full pulpotomy (FP)Procedure or surgery

    Also called Full pulpotomy

    Procedure: FP

    The FP will be performed as follow:

    • Anesthesia
    • isolation the tooth
    • access to the lesion
    • complete removal of carious tissue from the cavity walls result in pulp exposure
    • pulpotomy
    • preparation of clot-free pulpal mound
    • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
    • permanent filling with sandwich technique
Study groups in NCT01561183
Study groupRoleWhat they receive
Indirect pulp capping (IPC)ExperimentalIndirect pulp capping
Receives: Procedure: Indirect pulp capping (IPC)
Direct pulp capping (DPC)ExperimentalDirect pulp capping
Receives: Procedure: Direct pulp capping (DPC)
Miniature pulpotomy (MP)ExperimentalMiniature pulpotomy
Receives: Procedure: Miniature pulpotomy (MP)
Full pulpotomy (FP)ExperimentalFull pulpotomy
Receives: Procedure: Full pulpotomy (FP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical and radiographical success rates (%) of each treatment group

    The outcome of clinical success/failure is determined by subjective symptoms and objective observation of inflammation/infection.

    The outcome of radiographic success is classified by using a modification of the Strindberg criteria.

    Measured: 1 year

Secondary outcomes (1)
  1. Patient Assessment of Pain with questionnaire

    Pain assessment is carried out using the pain Numerical Rating Scale (NRS) with ratings between 0 to 9. Pain assessment is made up to 7 days. One NRS form is given to each patient to complete.

    Measured: 6-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2012 (estimated)
  2. Study startMar 2012
  3. Primary completionMar 2014
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
302 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01561183
Sponsor's protocol ID
IKHDC: 01-11-1390
Status last verified
Apr 2017
First submitted
14 Mar 2012
Last updated
28 Apr 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Asgary S, Ahmadyar M. Can miniature pulpotomy procedure improve treatment outcomes of direct pulp capping? Med Hypotheses. 2012 Feb;78(2):283-5. doi: 10.1016/j.mehy.2011.11.002. Epub 2011 Dec 1.

    PubMed 22137499

Questions about this trial

What is this clinical trial studying?

A study testing Indirect pulp capping (IPC), Direct pulp capping (DPC) and Miniature pulpotomy (MP) in people with Irreversible Pulpitis, run by Shahid Beheshti University of Medical Sciences at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical and radiographical success rates (%) of each treatment group (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01561183, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in